Pre-earnings options volume in Revolution Medicines is normal with puts leading calls 4:3. Implied volatility suggests the market is anticipating a move near 4.7%, or $1.02, after results are released. Median move over the past eight quarters is 2.5%.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RVMD:
- RVMD Earnings this Week: How Will it Perform?
- Revolution Medicines says independent proxy recommend ‘FOR’ EQRx acquisition
- Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Revolution Medicines Stockholders Vote “FOR” Proposed Acquisition of EQRx, Inc.
- Revolution Medicines to Report Financial Results for Third Quarter 2023 After Market Close on November 6, 2023
- Revolution Medicines reports objective response rate in RMC-6236 trial of 38%